AA
WGSWW

AQR Arbitrage’s GeneDx Holdings Warrant WGSWW Stock Holding History

AQR Arbitrage’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50,629
Closed -$233K – 1208
2021
Q2 		$233K Hold
50,629
– – 0.01% 745
2021
Q1 		$256K Sell
50,629
-161,917
-76% -$900K 0.01% 735
2020
Q4 		$580K Buy
+212,546
New +$534K 0.02% 592

Other funds holding WGSWW

SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

AQR Arbitrage's WGSWW Position: Q3 2021 in Review

AQR Arbitrage sold out of GeneDx Holdings Warrant (WGSWW) in Q3 2021, closing a stake of 50,629 shares — an estimated $233K sold.

AQR Arbitrage first reported a position in WGSWW in Q4 2020 and held it in 3 quarters. The position peaked at $580K in Q4 2020. 35 funds tracked by Wall St. Rank hold WGSWW as of Q3 2021.

  • AQR Arbitrage reported no remaining GeneDx Holdings Warrant position as of Q3 2021 after selling out during the quarter.
  • AQR Arbitrage sold 50,629 GeneDx Holdings Warrant shares in Q3 2021, an estimated $233K.
  • AQR Arbitrage first reported a position in GeneDx Holdings Warrant in Q4 2020 and held it in 3 quarters.
  • AQR Arbitrage's GeneDx Holdings Warrant position peaked at $580K in Q4 2020.
  • 35 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q3 2021.

Based on AQR Arbitrage's 13F filing for Q3 2021, filed 15 Nov 2021.